Quantcast

Latest Sagent Pharmaceuticals Inc. Stories

2011-04-26 13:56:00

SCHAUMBURG, Ill., April 26, 2011 /PRNewswire/ -- Sagent Pharmaceuticals, Inc. (the "Company") (Nasdaq: SGNT) today announced that it has closed its previously announced initial public offering of 5,750,000 shares of its common stock at a price to the public of $16.00 per share.

2010-12-02 16:06:00

SCHAUMBURG, Ill., Dec. 2, 2010 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, today announced U.S. FDA approval and launch of its topotecan hydrochloride for injection, a chemotherapy agent, in conjunction with the innovator's patent expiry.

2010-12-02 11:13:00

SCHAUMBURG, Ill., Dec. 2, 2010 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, today announced U.S. FDA's approval of four presentations of midazolam injection, USP, a general anesthetic.

2010-10-18 07:00:00

SCHAUMBURG, Ill., Oct. 18 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced the commercial launch of ANEclear((TM)), an easy-to-use, disposable anesthesia recovery device at the American Society of Anesthesia (ASA) meeting in San Diego.

2010-10-05 07:00:00

SCHAUMBURG, Ill., Oct. 5 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that it has launched ampicillin and sulbactam for injection, USP and ampicillin for injection, USP.

2010-08-02 07:00:00

SCHAUMBURG, Ill., Aug. 2 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, today announced two FDA approvals -- sumatriptan succinate injection and rocuronium bromide injection.

2010-07-01 07:00:00

SCHAUMBURG, Ill., July 1 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's nine presentations of heparin sodium injection, USP.

2010-06-02 11:47:00

SCHAUMBURG, Ill., June 2 /PRNewswire/ -- Sagent Pharmaceuticals, Inc. today announced the voluntary nationwide recall of all lots of ondansetron injection in 5% dextrose 32mg / 50 mL (NDC number 25021-776-50) manufactured by Claris Lifesciences and distributed by Sagent.


Word of the Day
gawf
  • In costermongers' slang, a cheap red-skinned apple, which is rubbed hard with a cloth to give it the appearance and feeling of an apple of superior quality.
The origin of the word 'gawf' is obscure, but may come from the phrase 'go for more'.